Literature DB >> 28677860

Molecular Magnetic Resonance Imaging of Lung Fibrogenesis with an Oxyamine-Based Probe.

Philip A Waghorn1, Chloe M Jones1, Nicholas J Rotile1, Steffi K Koerner1, Diego S Ferreira1, Howard H Chen1, Clemens K Probst2, Andrew M Tager2, Peter Caravan1.   

Abstract

Fibrogenesis is the active production of extracellular matrix in response to tissue injury. In many chronic diseases persistent fibrogenesis results in the accumulation of scar tissue, which can lead to organ failure and death. However, no non-invasive technique exists to assess this key biological process. All tissue fibrogenesis results in the formation of allysine, which enables collagen cross-linking and leads to tissue stiffening and scar formation. We report herein a novel allysine-binding gadolinium chelate (GdOA), that can non-invasively detect and quantify the extent of fibrogenesis using magnetic resonance imaging (MRI). We demonstrate that GdOA signal enhancement correlates with the extent of the disease and is sensitive to a therapeutic response.
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  aldehydes; allysine; collagen; fibrosis; imaging agents

Mesh:

Substances:

Year:  2017        PMID: 28677860      PMCID: PMC5558833          DOI: 10.1002/anie.201704773

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  29 in total

Review 1.  Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell.

Authors:  Herbert M Kagan; Wande Li
Journal:  J Cell Biochem       Date:  2003-03-01       Impact factor: 4.429

2.  Clinical safety and diagnostic value of the gadolinium chelate gadoterate meglumine (Gd-DOTA).

Authors:  Christoph U Herborn; Elmar Honold; Michael Wolf; Jörn Kemper; Sonja Kinner; Gerhard Adam; Jörg Barkhausen
Journal:  Invest Radiol       Date:  2007-01       Impact factor: 6.016

3.  Incidence and prevalence of idiopathic pulmonary fibrosis.

Authors:  Ganesh Raghu; Derek Weycker; John Edelsberg; Williamson Z Bradford; Gerry Oster
Journal:  Am J Respir Crit Care Med       Date:  2006-06-29       Impact factor: 21.405

4.  Studies on bleomycin.

Authors:  H Umezawa; M Ishizuka; K Maeda; T Takeuchi
Journal:  Cancer       Date:  1967-05       Impact factor: 6.860

5.  The nature and location of intramolecular cross-links in collagen.

Authors:  P Bornstein; A H Kang; K A Piez
Journal:  Proc Natl Acad Sci U S A       Date:  1966-02       Impact factor: 11.205

6.  Molecular MRI of collagen to diagnose and stage liver fibrosis.

Authors:  Bryan C Fuchs; Huifang Wang; Yan Yang; Lan Wei; Miloslav Polasek; Daniel T Schühle; Gregory Y Lauwers; Ashfaq Parkar; Anthony J Sinskey; Kenneth K Tanabe; Peter Caravan
Journal:  J Hepatol       Date:  2013-07-06       Impact factor: 25.083

7.  High-performance liquid chromatographic quantification of allysine as bis-p-cresol derivative in elastin.

Authors:  H Umeda; K Kawamorita; K Suyama
Journal:  Amino Acids       Date:  2001       Impact factor: 3.520

8.  Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003.

Authors:  Amy L Olson; Jeffrey J Swigris; Dennis C Lezotte; Jill M Norris; Carla G Wilson; Kevin K Brown
Journal:  Am J Respir Crit Care Med       Date:  2007-05-03       Impact factor: 21.405

9.  Biosynthesis of collagen crosslinks: increased activity of purified lysyl oxidase with reconstituted collagen fibrils.

Authors:  R C Siegel
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

Review 10.  Therapy for fibrotic diseases: nearing the starting line.

Authors:  Scott L Friedman; Dean Sheppard; Jeremy S Duffield; Shelia Violette
Journal:  Sci Transl Med       Date:  2013-01-09       Impact factor: 17.956

View more
  13 in total

Review 1.  Advances in functional and molecular MRI technologies in chronic liver diseases.

Authors:  Iris Y Zhou; Onofrio A Catalano; Peter Caravan
Journal:  J Hepatol       Date:  2020-06-22       Impact factor: 25.083

Review 2.  Matrix biomechanics and dynamics in pulmonary fibrosis.

Authors:  Andrew J Haak; Qi Tan; Daniel J Tschumperlin
Journal:  Matrix Biol       Date:  2017-12-21       Impact factor: 11.583

Review 3.  Novel Imaging Approaches in Systemic Sclerosis-Associated Interstitial Lung Disease.

Authors:  Sydney B Montesi; Peter Caravan
Journal:  Curr Rheumatol Rep       Date:  2019-04-25       Impact factor: 4.592

Review 4.  Noninvasive assessment of renal fibrosis by magnetic resonance imaging and ultrasound techniques.

Authors:  Kai Jiang; Christopher M Ferguson; Lilach O Lerman
Journal:  Transl Res       Date:  2019-04-22       Impact factor: 7.012

5.  Molecular Magnetic Resonance Imaging with Gd(III)-Based Contrast Agents: Challenges and Key Advances.

Authors:  Hao Li; Thomas J Meade
Journal:  J Am Chem Soc       Date:  2019-10-17       Impact factor: 15.419

6.  68Ga-NODAGA-Indole: An Allysine-Reactive Positron Emission Tomography Probe for Molecular Imaging of Pulmonary Fibrogenesis.

Authors:  Jessica Wahsner; Pauline Désogère; Eric Abston; Katherine A Graham-O'Regan; Junfeng Wang; Nicholas J Rotile; Markus D Schirmer; Diêgo Dos Santos Ferreira; Jingyi Sui; Bryan C Fuchs; Michael Lanuti; Peter Caravan
Journal:  J Am Chem Soc       Date:  2019-03-27       Impact factor: 15.419

Review 7.  Molecular imaging of fibrosis: recent advances and future directions.

Authors:  Sydney B Montesi; Pauline Désogère; Bryan C Fuchs; Peter Caravan
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

Review 8.  Advances in gadolinium-based MRI contrast agent designs for monitoring biological processes in vivo.

Authors:  Jacques Lux; A Dean Sherry
Journal:  Curr Opin Chem Biol       Date:  2018-05-09       Impact factor: 8.822

Review 9.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

10.  Toward Molecular Imaging of Intestinal Pathology.

Authors:  Mariane Le Fur; Iris Y Zhou; Onofrio Catalano; Peter Caravan
Journal:  Inflamm Bowel Dis       Date:  2020-09-18       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.